NHS England has appointed IBM as a strategic delivery partner for the next phase of the NHS App, awarding a contract worth up to £160 million in a move that signals the scale of ambition behind its digital front door.
The agreement, which runs from May 2026 through to March 2028, formalises IBM’s role in shaping the infrastructure, delivery and evolution of one of the NHS’s most visible patient-facing platforms. It follows a competitive procurement process and comes at a moment when the App is no longer a supporting service but an increasingly central layer of the health system itself.
A spokesperson for NHS England described the appointment as part of a broader push to deliver “secure, reliable and user-centred pathways and services at scale.” The language reflects a shift in emphasis, away from standalone digital tools and towards integrated, system-wide access points that can operate with consistency across regions and care settings.
That direction has already been set at the highest level. Within the government’s 10 Year Health Plan, the NHS App is positioned not simply as a convenience layer but as the primary interface between patient and system. Plans include AI-enabled triage, integration with wearable technologies, and direct linkage into the emerging Single Patient Record.
For Sir Jim Mackey, the intent is clear. The App is expected to become “a doctor in their pocket,” offering patients greater control over how they access, understand and manage their care. The ambition is not incremental improvement, but the creation of a single, coherent front door to the NHS.
The scale of adoption already suggests that this transition is well underway. The platform has surpassed 39 million registered users, with monthly engagement reaching tens of millions of logins. Over the past year alone, more than 67 million repeat prescriptions have been ordered through the App, quietly embedding it into routine patient behaviour rather than episodic use.
For Zubir Ahmed, these figures represent more than usage metrics. They are early indicators of a system shifting from analogue processes to digital pathways at scale. Recent updates, including prescription tracking and expanded family features, are framed as incremental steps towards a broader “virtual hospital” model, where elements of care are delivered, monitored and managed remotely.
The roadmap now moves into a more advanced phase. Pilots of AI-enabled triage within primary care are being expanded, while new services, such as integrated RSV vaccination booking, point towards a more unified approach to prevention and population health. A centralised vaccinations hub is also in development, alongside wider rollout of online consultation services designed to absorb demand that would otherwise sit within traditional settings.
Beyond the App itself, the wider system is beginning to align around the same patient-facing logic. At Humber Teaching NHS Foundation Trust, new functionality is being rolled out to allow patients to manage appointments directly, with integration into electronic patient records enabling real-time visibility of bookings, notifications and clinical documentation. The model is expected to extend across multiple trusts, particularly those operating on shared platforms such as SystmOne.
Elsewhere, digital self-management is being embedded into care pathways. Bristol, North Somerset and South Gloucestershire ICB has commissioned a region-wide musculoskeletal platform to support patients across primary, community and secondary care, reflecting a growing emphasis on guided self-care as a core component of service delivery.
At the same time, more advanced technologies are beginning to reshape clinical interaction itself. At Chelsea and Westminster Hospital NHS Foundation Trust, augmented reality tools are now part of routine practice in women’s health, enabling clinicians and patients to visualise complex conditions such as endometriosis in three dimensions, improving both understanding and surgical planning.
Taken together, these developments point to a system moving in a single direction. The NHS App is no longer a standalone product but the organising interface through which patients, data and services increasingly converge. IBM’s appointment, in that context, is less about delivery support and more about enabling the infrastructure required to sustain that convergence at national scale.
